CLOs on the Move

Xencor

www.xencor.com

 
Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.xencor.com
  • 111 West Lemon Avenue
    Monrovia, CA USA 91016
  • Phone: 626.305.5900

Executives

Name Title Contact Details
Eric Chang
 Associate Director, Intellectual Property Profile
Evan Moll
 Associate General Counsel Profile
Lloyd Rowland
 General Counsel Profile

Similar Companies

Infinite Digital Sol

Williams-Labadie Advertising

Williams-Labadie Advertising is a Chicago, IL-based company in the Business Services sector.

Northampton Manor

Northampton Manor is a Frederick, MD-based company in the Business Services sector.

M Squared Group

M Squared Group is a Eden Prairie, MN-based company in the Business Services sector.

Shore Capital Partners

Shore Capital Partners is a private equity firm based in Chicago, with additional offices in Nashville. The firm specializes in microcap investments across various sectors, including healthcare, food and beverage, business services, industrial, and real estate. Founded by Justin Ishbia, Shore focuses on partnering with small to mid-sized companies to drive growth through consolidation, operational improvements, and strategic acquisitions. The firm provides capital investment, operational support, and acquisition expertise to help its portfolio companies scale efficiently. Shore employs a "buy and build" strategy that emphasizes industry consolidation and shared learnings across its network of over 50 portfolio companies. With a dedicated team of more than 35,000 professionals, Shore offers hands-on support in technology, talent development, and process optimization. Shore targets established private companies with stable cash flow and strong management teams, aiming for growth through organic expansion or add-on acquisitions. The firm manages over $6 billion in assets and has been recognized for its achievements, including being named to Inc. Magazine’s Founder-Friendly Investors list for five consecutive years.